The Foodstuff and Drug Administration first approved the injectable medication for managing diabetes in 2017; the company accepted a drug with a higher dose with the active component in copyright, termed semaglutide, to treat being overweight in 2021, beneath the brand name Wegovy. Since then, talk in the drug has popped up throughout the internet.